Aspire Biopharma Holdings, Inc. (ASBP)
NASDAQ: ASBP · Real-Time Price · USD
0.209
-0.036 (-14.82%)
At close: Apr 28, 2026, 4:00 PM EDT
0.205
-0.004 (-2.01%)
After-hours: Apr 28, 2026, 4:30 PM EDT
Aspire Biopharma Holdings Market Cap
Aspire Biopharma Holdings has a market cap or net worth of $1.03 million as of April 28, 2026. Its market cap has decreased by -99.99% in one year.
Market Cap
1.03M
Enterprise Value
5.40M
1-Year Change
-99.99%
Ranking
Category
Stock Price
$0.21
Market Cap Chart
Since April 11, 2022, Aspire Biopharma Holdings's market cap has decreased from $349.65M to $1.03M, a decrease of -99.71%. That is a compound annual growth rate of -76.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 1.23M | -91.32% |
| Dec 31, 2025 | 14.18M | -84.12% |
| Dec 18, 2024 | 89.30M | -8.80% |
| Dec 29, 2023 | 97.91M | -73.55% |
| Dec 30, 2022 | 370.16M | 5.86% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Scinai Immunotherapeutics | 2.56M |
| HCW Biologics | 2.53M |
| Calidi Biotherapeutics | 2.50M |
| Bone Biologics | 2.44M |
| Propanc Biopharma | 2.30M |
| Adial Pharmaceuticals | 2.26M |
| Biodexa Pharmaceuticals | 2.14M |
| CNS Pharmaceuticals | 1.91M |